You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Hepatitis

Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B

  • Technology appraisal guidance
  • Reference number: TA96
  • Published:  22 February 2006
  • Guidance
  • Tools and resources
  • Information for the public
  • History

People with chronic hepatitis B to benefit from guidance on new drugs and treatments

The National Institute for Health and Clinical Excellence (NICE) has today (22 February) issued guidance for the NHS in England and Wales recommending the use of two new drugs for treating hepatitis B.

People with chronic hepatitis B to benefit from guidance on new drugs and treatments People with chronic hepatitis B to benefit from guidance on new drugs and treatments
22 February 2006
(47.11 Kb 13 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 02 January 2011

Back to top